Management Team

Jennifer J. Davagian - Founder, CEO

Inventor of the Sephure delivery technology and the drug formulation for its HCA suppository. Designed and wrote the clinical trial protocols; conducts all regulatory correspondences and maintains a collaborative working relationship with the FDA.

Mark C. Ensign - Founder - COO/CSO

Knowledgeable in medical device engineering, suppository formulation and development, and drug-device combination product testing and manufacturing.

Mark A. Parent - CFO

Oversees the company finance operations and drafts market and cash flow forecasts.

Board of Directors

Jennifer J. Davagian - CEO

Ernest Pomerantz - Private Investor, formerly of Warburg Pincus

James Bartlett -  Private Investor, formerly of Primus Venture Partners

Henry Kay -  Private Investor, formerly of Allergan and Boston Scientific

John S. Davagian II -  Attorney, Private Investor

Richard Warburg -  Patent Attorney, Experienced executive in FDA approvals for pharmaceuticals and devices

David Shepherd -  Private Investor, Principal, Shepherd, Kaplan, Krochuk

Rory Riggs (observer) 
Co-founder, Royalty Pharma
Founder and CEO, Cibus, Syntax & Locus Analytics